AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 9

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 98.98 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020702CJC-1295 (no DAC)SGNSGN-2412-L9210Janoshik2025-Q299.274.93105.7Buyer-sourced0PASS
AX-2025-020395TirzepatideMKMMKM-2411-B3993Janoshik2025-Q297.933.62Buyer-sourced0PASS
AX-2025-019816SemaglutideHomopeptideHOMO-2501-A5192Kestrel2025-Q299.936.25102.4Buyer-sourced0PASS
AX-2025-018912CJC-1295 with DACTFSTFS-{CAT}-1220Janoshik2025-Q298.754.74Buyer-sourced1MARGINAL
AX-2025-018661SemaglutideQSCQSC-2412-F6175Medutest2025-Q298.802.77Buyer-sourced0PASS
AX-2025-018574N-Acetyl Semax AmideQYBQYB-2411-G5028Medutest2025-Q299.939.34Buyer-sourced0PASS
AX-2025-021161IpamorelinPPGPPG-2505-U7155Janoshik2025-Q299.704.5592.9Buyer-sourced0PASS
AX-2025-020919SurvodutideWXTWXT-2501-X2463Janoshik2025-Q297.793.8894.0Buyer-sourced2MARGINAL
AX-2025-020250IpamorelinGGPepsGGPE-2411-B1929Janoshik2025-Q299.215.16Buyer-sourced0PASS
AX-2025-020245IpamorelinGGPepsGGPE-2411-B1929Janoshik2025-Q298.994.3493.4Buyer-sourced0FAIL
AX-2025-0195095-Amino-1MQJEEPJEEP-2412-M9286PeptideMeter2025-Q299.355.87Buyer-sourced0FAIL
AX-2025-019007RetatrutideASYASY-{CAT}-2342VendorInvestigate2025-Q298.440.90Buyer-sourced1MARGINAL
AX-2025-018887CJC-1295 (no DAC)TFSTFS-{CAT}-9097Janoshik2025-Q298.753.51Buyer-sourced0PASS
AX-2025-018771MK-677 (Ibutamoren mesylate)FGPFGP-2502-F7880Janoshik2025-Q299.454.21Buyer-sourced0FAIL
AX-2025-021078MOTS-cBCHBCH-2505-J4599Janoshik2025-Q298.292.70106.6Buyer-sourced0PASS
AX-2025-020704MGFSGNSGN-2503-S9261PeptideMeter2025-Q299.393.50104.6Buyer-sourced0PASS
AX-2025-019753TirzepatideHomopeptideHOMO-2502-U4118Janoshik2025-Q298.106.14100.0Buyer-sourced0PASS
AX-2025-019234AOD-9604AMBAMB-2411-S5560Janoshik2025-Q299.664.93Buyer-sourced0PASS
AX-2025-018906CJC-1295 with DACTFSTFS-{CAT}-1220PeptideMeter2025-Q298.494.63105.9Buyer-sourced1MARGINAL
AX-2025-018698TB-500QSCQSC-2504-T6759VendorInvestigate2025-Q299.603.22Buyer-sourced1MARGINAL
AX-2025-018616GHRP-6QYBQYB-2504-H5023PeptideMeter2025-Q299.506.05Buyer-sourced0PASS
AX-2025-020736TriptorelinSGNSGN-2504-A9334Nordanalyt2025-Q299.494.46Supplier-supplied0PASS
AX-2025-020059RetatrutideSWBSWB-2503-P7565PeptideMeter2025-Q297.955.1894.3Buyer-sourced1MARGINAL
AX-2025-019382MK-677 (Ibutamoren mesylate)HYBHYB-2505-M6859Janoshik2025-Q299.874.94101.4Buyer-sourced0FAIL
AX-2025-018700TB-500QSCQSC-2504-T6759Medutest2025-Q299.663.57Buyer-sourced1MARGINAL
AX-2025-018622GHRP-6QYBQYB-2504-H5023Janoshik2025-Q299.656.68Buyer-sourced0PASS
AX-2025-018504CJC-1295 with DACWWBWWB-2503-U2989Janoshik2025-Q299.735.11Buyer-sourced0PASS
AX-2025-0208915-Amino-1MQWXTWXT-2505-M2430VendorInvestigate2025-Q298.803.32104.8Buyer-sourced0FAIL
AX-2025-020741TriptorelinSGNSGN-2504-A9334VendorInvestigate2025-Q298.485.10Buyer-sourced0FAIL
AX-2025-019960RetatrutideHJHJ-2412-C6855Janoshik2025-Q297.513.82Buyer-sourced0PASS
AX-2025-019815SemaglutideHomopeptideHOMO-2501-A5192Janoshik2025-Q299.605.85Buyer-sourced0PASS
AX-2025-019383MK-677 (Ibutamoren mesylate)HYBHYB-2505-M6859Kestrel2025-Q299.825.1999.8Buyer-sourced0FAIL
AX-2025-019172TirzepatideSinoPepSNP-2505-A3973Janoshik2025-Q298.984.48Buyer-sourced0PASS
AX-2025-020987ARA-290WXTWXT-2502-N3730PeptideMeter2025-Q298.744.21Buyer-sourced1MARGINAL
AX-2025-020914SurvodutideWXTWXT-2501-X2463PeptideMeter2025-Q297.954.2693.0Buyer-sourced2MARGINAL
AX-2025-020913SurvodutideWXTWXT-2501-X2463PeptideMeter2025-Q298.514.13Buyer-sourced2MARGINAL
AX-2025-0208885-Amino-1MQWXTWXT-2505-M2430Janoshik2025-Q298.512.7589.4Buyer-sourced1FAIL
AX-2025-020762TirzepatideSGNSGN-2503-P9641Nordanalyt2025-Q297.864.14Buyer-sourced1MARGINAL
AX-2025-020401TirzepatideMKMMKM-2411-B3993Medutest2025-Q298.134.02Buyer-sourced0PASS
AX-2025-020030IpamorelinSWBSWB-2501-Y7592VendorInvestigate2025-Q299.174.12101.1Buyer-sourced1MARGINAL